InsidersTradesSigma
Browse the detailed record of transactions filed by Armitage James O, Director. Insider active across 1 companies, notably Cardiff Oncology, Inc.. Cumulatively, 2 reports have been logged. Total volume traded: €73k. The latest transaction was disclosed on 19 March 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
James O. Armitage is a Board Member at Cardiff Oncology, Inc. He plays a key role in the governance of the company, influencing strategic decisions and contributing to its development.